Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS).
about
Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study.A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone MetastasesEGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic seriesRacial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study.Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer.Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysisEpidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) - Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy.Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China.Gefitinib for advanced non-small cell lung cancer.Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation.
P2860
Q35028752-B2F14565-2DFB-4254-AC7C-55EDA85B1998Q36106373-A59242A4-0210-447D-A885-71EADCCB1CBAQ36216134-07D35120-A5F6-450A-BE17-2ADB79BEAD62Q36250691-9F65B0FA-E2CE-42EA-9B07-F4D3D77DD9F6Q37296060-EC73A9A6-8B5F-4BA7-A1BB-E85599317407Q37684483-6981C3AE-B71B-4D75-9651-0C289C9E68B4Q38386062-D3C054C8-AD7F-4575-9109-B05D3FABA215Q41417865-D7B9806F-F9D9-4A79-84AD-D6A4B516FB31Q41709088-67325D28-F635-4CE6-98E9-6EFD208F1FA6Q47261688-057D03E1-1313-42F4-A3BD-C841B5E03906Q47935277-3C3270CC-D3E6-49C1-81B1-6AAFCA2B7129Q50041281-AFE894F3-B599-402B-BDA3-6FA289DEB448Q51112153-47DCFF9B-9287-494F-B4C0-DB8655EA5CF5
P2860
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS).
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@ast
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@en
type
label
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@ast
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@en
prefLabel
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@ast
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS).
@en
P2093
P50
P1433
P1476
Epidermal growth factor recept ...... Iressa Pan-ASia Study (IPASS)
@en
P2093
Gael McWalter
Johan Kurnianda
Kazuhiko Nakagawa
Masahiro Fukuoka
Nagahiro Saijo
Rose McCormack
Valorie Chan
P304
P356
10.1016/J.LUNGCAN.2013.11.021
P577
2013-12-01T00:00:00Z